Seeyond Novavax Inc Transaction History

Seeyond

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $1,705 - $3,538	-47 Reduced 1.97%	2,334 $120,000
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $3,347 - $6,859	-48 Reduced 1.98%	2,381 $175,000
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $189,729 - $307,337	-1,410 Reduced 36.73%	2,429 $347,000
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $682,574 - $1.04 Million	3,839 New	3,839 $795,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

Stay updated on Seeyond with notifications on news.